Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

This study has been terminated.
(Analysis of data from 104RA203 failed to meet primary endpoint.)
Sponsor:
Information provided by (Responsible Party):
Biogen
ClinicalTrials.gov Identifier:
NCT00523328
First received: August 17, 2007
Last updated: December 17, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2008
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: December 17, 2015